HYE-JIN GEHRING: Open Payments
NPI 1457623027 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,743 in 335 payments from 19 companies in 2025. Trend: 2023 $6,184 · 2024 $5,486 · 2025 $15,743
Food & beverage: $7,118Speaker / faculty: $6,342Travel & lodging: $1,471Consulting: $600Education: $211
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 44 | $8,839 |
| ABBVIE INC. | 51 | $1,173 |
| Arcutis Biotherapeutics, Inc. | 31 | $1,042 |
| GENZYME CORPORATION | 18 | $834 |
| PFIZER INC. | 31 | $709 |
| Regeneron Healthcare Solutions, Inc. | 17 | $454 |
| Janssen Biotech, Inc. | 20 | $441 |
| Incyte Corporation | 14 | $381 |
| Galderma Laboratories, L.P. | 20 | $359 |
| Novartis Pharmaceuticals Corporation | 25 | $330 |
Products named: Bimzelx, DUPIXENT, Zoryve, CIBINQO, SKYRIZI, RINVOQ, TREMFYA, OPZELURA.
Industry payments across WA — which companies pay providers there.
